In conclusion, this research confirms that MIAT is highly expressed but miR-378a-5p expression is low in breast cancer cells, and MIAT silencing inhibits the viability and proliferation of breast cancer cells by promoting the expression of miR-378a-5p. Here, MIAT is linked to breast carcinoma.